company background image
3692 logo

Hansoh Pharmaceutical Group SHSC:3692 Stock Report

Last Price

HK$18.92

Market Cap

HK$112.3b

7D

1.8%

1Y

22.2%

Updated

02 Dec, 2024

Data

Company Financials +

Hansoh Pharmaceutical Group Company Limited

SHSC:3692 Stock Report

Market Cap: HK$112.3b

3692 Stock Overview

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. More details

3692 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends2/6

Hansoh Pharmaceutical Group Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hansoh Pharmaceutical Group
Historical stock prices
Current Share PriceHK$18.92
52 Week HighHK$22.80
52 Week LowHK$11.18
Beta0.65
11 Month Change6.05%
3 Month Change-3.47%
1 Year Change22.22%
33 Year Change14.39%
5 Year Change-16.65%
Change since IPO-24.02%

Recent News & Updates

Recent updates

Shareholder Returns

3692HK PharmaceuticalsHK Market
7D1.8%2.0%1.4%
1Y22.2%-7.0%14.9%

Return vs Industry: 3692 exceeded the Hong Kong Pharmaceuticals industry which returned -9.3% over the past year.

Return vs Market: 3692 exceeded the Hong Kong Market which returned 13.1% over the past year.

Price Volatility

Is 3692's price volatile compared to industry and market?
3692 volatility
3692 Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement6.7%
Market Average Movement8.9%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.2%

Stable Share Price: 3692 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 3692's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19959,099Huijuan Zhongwww.hspharm.com

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-tumor, anti-infection, central nervous system diseases, oncology, metabolic and autoimmune diseases, etc. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Hengmu, Mailingda, Hengsen, XINYUE, Saint Luolai, Fulaimei, Pulaitan, Tanneng, Ameining, Oulanning, Ruibote, Fulaidi, Fulairui, and Puruian tablets. The company serves pharmaceutical product distributors.

Hansoh Pharmaceutical Group Company Limited Fundamentals Summary

How do Hansoh Pharmaceutical Group's earnings and revenue compare to its market cap?
3692 fundamental statistics
Market capHK$112.28b
Earnings (TTM)HK$5.04b
Revenue (TTM)HK$12.94b

22.3x

P/E Ratio

8.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3692 income statement (TTM)
RevenueCN¥12.10b
Cost of RevenueCN¥1.09b
Gross ProfitCN¥11.01b
Other ExpensesCN¥6.30b
EarningsCN¥4.71b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.79
Gross Margin91.01%
Net Profit Margin38.97%
Debt/Equity Ratio0.1%

How did 3692 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

40%

Payout Ratio